Top 5 Most Read Articles in June you Shouldn’t Miss!


Hello there,

In this brand new month, we are here once again to tell you about the top 5 articles from biotech and pharma industries that you liked most.


#1 Microalgae- We See Future in This Tiny But Smart Organism

In this post, our editor Tiash Saha under the eminent guidance of Prof Lala Behari Shukla, Director of Institute for Applied Environmental Biotechnology Innovation (IAEBI), Bhubaneswar, Odisha tried to zoom into the vast opportunities that the tiny organisms, microalgae has placed before the startups and entrepreneurs in the form of microalgae technology for the development of green energy in India. You can read full blog post here.



#2 Mylan and Biocon Unveil Phase III Success Story of Cancer Biosimilar

This post covered the successful Phase III clinical study of MYL-14010 developed collaboratively by Mylan and its Indian partner, Biocon. It is a biosimilar version of Roche’s FDA approved breast cancer drug, trastuzumab (Herceptin).  Please read this post here.



#3 Seizures, Fits…Still Fighting Dravet Syndrome Bravely

On the occasion of ‘International Dravet Syndrome Awareness Day’ we tried to spread an awareness about the rare, genetic, epileptic neurodegenerative disorder occurring in infants, Dravet syndrome and tried to provide an insight about disease and related therapeutics development. Please read this post here.

dravet syndrome brain


#4 FDA Approves First Liquid Biopsy Test for Lung Cancer

This article elaborated about the first FDA approved liquid diagnostic test, Roche’s Liquid Biopsy test, Cobas®EGFR Mutation Test v2. It is developed as a companion diagnostic tool for the detection of gene mutations associated with one of the most common type of lung cancer, non-small cell lung cancer (NSCLC). You can read this post here.

Roche’s Liquid Biopsy test, Cobas® EGFR Mutation Test v2 FDA approval


#5 India’s Swagene Launched Personalized Medicine for Children with Blood Cancer

The article tried to bring the attention of people towards the India’s young molecular diagnostics company, Swagene which is the first and the only center in India to launch some of the advanced biomarkers for the benefit of children suffering from leukemia. You can read this post here.



Featured image credit: top 5 charts © kikkerdirk (Stock Photo ID: 128677853)

One comment

Leave a reply

Your email address will not be published. Required fields are marked *